Drug recall
Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by…
FDA recall event 83702 · Class II · Pacifico National, Inc. dba AmEx Pharmacy
Key facts
| Event ID | 83702 |
|---|---|
| Recall numbers | D-1849-2019, D-1850-2019 |
| Recalling firm | Pacifico National, Inc. dba AmEx Pharmacy |
| Product type | Drugs |
| Products | Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901, Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Lack of assurance of sterility. |
| Initiation date | Aug 30, 2019 |
| Report date | Sep 18, 2019 |
| Termination date | Oct 8, 2020 |
| City | Melbourne |
| State | FL |
| Country | United States |
| FEI number | 3012034698 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: